EDITORIAL. In the news : TRUFFLE IN THE NEWS. N 14 - February 2010
|
|
- Octavia Barber
- 6 years ago
- Views:
Transcription
1 N 14 - February 2010 Truffle Capital 5, rue de la Baume Paris Tel: In the news : Truffle in the news Truffle 100 France Highlight Truffle 100 European Clusters Portfolio News Information Technologies : GoAdv, Keyyo, NetBooster, Nexeya Life Sciences : Theraclion, Neovacs Energy : Watteco, Dietswell Contacts EDITORIAL Has economic growth returned? After a difficult 2009, 2010 should be less morose than initially expected. The International Monetary Fund has raised its growth forecast and announced that the global economy should grow by 3.9% in Even though the "green shoots" of recovery are still fragile, we are witnessing renewed growth in most of our portfolio companies and remain optimistic for the coming months. It also looks like IPOs in the three innovative sectors that we cover are beginning to pick up, after a firmly closed stock market window over the last two years. In this latest issue of Truffle Insiders, we emphasize on the renewed growth for certain portfolio companies and the successful transition to a commercial phase for others. We hope that you will enjoy reading this issue of our newsletter. Henri Moulard Jean François Fourt Philippe Pouletty MD Bernard Louis Roques TRUFFLE IN THE NEWS In April 2010, Truffle Capital will unveil the 6th Edition of its Truffle 100 France, a reputed ranking of the country s top 100 software companies. Created in 2003, the Truffle 100 France has now become an important reference for the software industry in France.
2 HIGHLIGHT Truffle Capital launches the first edition of the "Truffle 100 European Clusters" ranking At a time when the French government has decided to launch a 35 billion National Bond Scheme (intended to boost the country's economic growth and competitiveness in key emerging sectors), it is becoming clear that France is losing the "software battle". This has been one of the conclusions of the "Truffle 100 European Clusters", a ranking of Europe's 42 leading hi tech regions. The ranking (published on January 20 th 2010) emphasized the domination of the German's Rhine Hand Neckar region which, thanks to the presence of industry leaders like SAP and Software AG, boasted over 12.5 billion in software related revenues for The best ranked French region (Paris Ile de France) came in second ( 2.4 billion in revenues), just ahead of South East England (comprising Greater London and with revenues of 1.8 billion). The two other French regions to make it into the ranking (Rhône Alpes and Nord Pas de Calais) finished in 12th and 20th position, respectively well behind the regions which matter in the world of software. 2
3 PORTFOLIO NEWS Information Technology In brief LeadMedia Group, a spin off of NetBooster specialized in qualified lead generation for advertisers, achieved its first post spin off report with a consolidated turnover of 8 million and a balanced result. In December, the company raised 1 million from its historical investors including Truffle Capital in order to develop its activities. In 2009, LeadMedia (founded by Stéphane Darracq) doubled its turnover and imposed itself as a major player in Internet based performance marketing. This tremendous success confirmed Truffle Capital s expertise in building technology leaders. MoMac, the leading mobile media publisher, announced the launch of its Global Reseller Program (GRP) and the creation of a new Reseller Division. The reseller program will see MoMac extend its reach Worldwide, partnering with best of breed mobile technology and marketing organizations who will use MoMac s GoMedia Platform to service local media, web brands and mobile operators. GoMedia is one the most advanced mobile publishing platforms of the market. GoAdv, Keyyo, NetBooster and Nexeya confirmed high growth trend GoAdv, one of the European specialists in generating qualified web traffic, reported Q unaudited revenues of 11.9 million, showing a strong performance over Q revenues of 9 million (+33%), and a very encouraging 25% growth on Q revenues of 9.6 million. Despite the bad market conditions, IT portfolio companies announced a strong growth. The Keyyo group (formerly Phone Systems & Network), France's leading VoIP operator for corporate clients, posted a turnover of 4.72 million for Q a 19.3% increase over Q In order to attract even more investors, Keyyo held a general assembly meeting on January 21 st. The Board agreed to transfer its shares to Alternext NYSE Euronext Paris. With a view to giving the company an open equity structure and, above all, boosting the stock s liquidity, Truffle Capital allowed its shareholding to fall below 50% as a result of the transfer. This operation also constituted a clear vote of confidence in the management team. 3
4 In Q4 2009, the online and interactive marketing group Netbooster reported a 34% increase of its turnover and gross margin increase of 19% over Q NetBooster is the main shareholder of Guava (29.89% equity stake), a Danish digital marketing agency listed on First North (part of the NASDAQ OMX Nordic Exchange) in Copenhagen. Established in the UK, Denmark and Sweden, Guava posted a turnover of 7.1 million in S and 4.9 million in Q Nexeya (initially Eurilogic Group) published a consolidated turnover of 52.1 million in the first semester , an increase of 1.9 % over the first semester of the previous year ( 51.1 million). Nexeya combines design, realization and support of most advanced electronic products and provides high value services in the fields of Defence, Aerospace and Transportation markets. The Product division (65% of the semestrial turnover) kept on growing with a 29% increase in the second quarter ( 19.6 million vs 15.2 million) and with a 25% increase in the semester ( 34.4 million vs 27.5 million). Life sciences In brief Vexim, the specialist in minimally invasive anatomical restoration of vertebral compression fractures, is actively preparing the commercialization of its implant, planned to be launched during the first half of Deinove, a biotech company dedicated to the research and development of innovative processes for biofuel production, has been selected to present at CleanEquity Monaco 2010, the foremost event for next generation clean and green technology. The conference will take place on March 4 th and 5 th at the Sporting d Hiver in Monaco. Theraclion validates its therapeutic approach and launches pre commercialization of TH One Theraclion, the only medtech company in the world specialized in the treatment of head and neck pathologies, obtained conclusive clinical results at the American society of Nephrology s 42 nd Annual Meeting and Scientific Exposition, which took place from October 27 th to November 1 st in San Diego, USA. This study confirmed the efficacy of Theraclion s therapeutic approach. After two ultrasound treatment sessions with the Theraclion s TH One device, a female patient suffering from primary hyperparathyroidism had normalized her parathyroid hormone level and her adenoma size had halved. No treatment side effects were observed. Now that Theraclion s technology is scientifically validated, the company is getting ready for the precommercialisation of its product, the TH One, a device treating primary and secondary hyperparathyroidism non invasively. The technology 4
5 N 14 February 2010 uses diagnostic ultrasound to identify the target and then high intensity ultrasound to coagulate the tissue thus enabling patients to avoid burdensome drug treatment and the risks of surgery. Theraclion has been preparing itself since a year for this major milestone. The company developed a strong brand identity (new corporate visual identity with notably the redesign of Theraclion s logo) and built marketing tools to back up pre commercialization and commercialization of its device (corporate movie and website). Founded in 2004, Theraclion is entering the pre commercialisation phase only 5 years after its creation. The company has, without a doubt, experienced a tremendous growth and has reached in a full speed the crucial stages of his development/expansion. Part financed by OSEO/ISI, the Phase IIa study will be performed in collaboration with the diagnostics company BMD, which is specialised in the diagnosis Neovacs initiates the Phase IIa clinical trial of TNFα kinoïde In December, the biotechnology company Neovacs announced the initiation of the Phase IIa clinical study of its TNFα kinoïde immunotherapy in rheumatoid arthritis patients, an articular pathology affecting over 9 million people in developed countries. 5
6 of autoimmune diseases. BMD recently announced a capital increase of 3 million led by Truffle Capital and AGF private Equity, who are now shareholders of the company. degeneration age related or AMD) has to raise 15 million to continue its development before envisaging a possible partnership. IPO is an option if the market conditions are favourable. Neovacs aims at commercialising the TNFα kinoïde medicine by Neovacs, working on other autoimmune diseases or serious chronics (Chron s disease, Psoriasis, Lupus (SLE) and macular Energy In brief A new investment for the Energy portfolio: Truffle Capital financed the very promising company SP3H. Based in Aix (South of France), the company has developed a micro analyzer which lowers fuel consumption, pollution levels and carbon dioxide emissions. RF it Solutions, an Austrian company selling software and services for radio frequency identification systems (RFID), announced the launch of detego SUITE, a new product using RFID technology, an automatic identification method, relying on storing and remotely retrieving data using devices called RFID tags or transponders. Created in 1998, Watecco manufactures Watt Pulse Watteco received the prestigious «Prix PME de l innovation numérique pour le développement durable» award On December 4 th, Watteco, a French based company developing a unique Power Line Communication solution, received the «Prix PME de l innovation numérique pour le développement durable», an award saluting the most innovative company developing digital technologies for sustainable development. Communication (WPC ) modems for the Smart Energy Command & Control market, including home control and street lighting applications. These smartgrid connected devices are low cost, low power, small in size and able to connect perfectly with internal and Modules WPC external electrical grids. Willing to help individuals manage their energy consumption, the company launched in January its energetic barometer, barowatttm, which helps control home electric consumption. 6
7 Dietswell New Engineering Contract for an Offshore Drilling Unit in Southeast Asia engineering services for the drilling modules. Work on this phase of the project will continue through Q The EDE will be followed by Detailed Engineering, Construction and finally commissioning of the unit. Dietswell announced the signature of a contract for designing a drilling unit and its integration onto an offshore platform. This project will be conducted in partnership with Doris Engineering and Hyundai Heavy Industries (HHI). This Offshore platform will be built for the South Korean Operator, DAEWOO International Exploration & Production. HHI, which will manage the construction and installation of the platform, has tasked DORIS with providing the Early Detailed Engineering (EDE). Dietswell is participating in the EDE, providing This new contract from a first class international consortium follows the successful execution of this project s FEED (Front End Engineering and Design) in 2009 and confirms the recognition of Dietswell s expertise in the design of offshore drilling solutions. Un opérateur de Dietswell 7
8 CONTACTS Investor Relations Sneha HIREMATH Truffle Capital 5 rue de la Baume Paris Tel.: sneha@truffle.com Web : Press Relations Caroline CARMAGNOL Alize RP 33, rue de Surène Paris Tel: Mob: Fax. : caroline@alizerp.com
Pascal Quiry March 2013
Please send any questions on this case study to the author via the mail box on the web site www.vernimmen.com Pascal Quiry March 2013 This document may not be used, reproduced or sold without the authorisation
More information- PRESS RELEASE April 6 th, 2007 PRESS RELEASE April 6 th, PRESS RELEASE -
GENFIT S FINANCIAL RESULTS FOR 2006: PROFITABLE FOR THE 7 TH CONSECUTIVE YEAR DESPITE STRONGER INVESTMENT to the BENEFIT of the DRUG CANDIDATE PIPELINE - Profitable for the 7th consecutive year - Renewed
More informationFULL-YEAR 2013 RESULTS IN LINE WITH EXPECTATIONS
FULL-YEAR 2013 RESULTS IN LINE WITH EXPECTATIONS Full-year 2013 sales up 13% Full-year gross margin of 70% Rigorous cost control and stabilization of operating expenses Significant reduction in cash burn
More informationQurius Shareholder Information Meeting, Zaltbommel August 30th, Ian HERLEVSEN, Director International Activities
Qurius Shareholder Information Meeting, Zaltbommel August 30th, 2012 Ian HERLEVSEN, Director International Activities Participants Ian Mac Hueg Herlevsen Director International Activities Mobile : +33
More informationHIGH-TECH INDUSTRIES BIOTECH IN FRANCE KEY INFO IN POINTS
HIGH-TECH INDUSTRIES BIOTECH IN FRANCE KEY INFO IN 10 POINTS 1 67 BILLION IN REVENUES The biotech-medtech industry accounted for around 330,000 direct and indirect jobs and 67 billion in sales in 2016
More informationExtract from annual report 2017/18
Extract from annual report 2017/18 Analysis and counting of cells. ChemoMete coffers high-quality equipment for cell counting and cell analysis within, among other, life science research and development
More informationPRESS RELEASE. Change at constant exchange rates. Change. Mail Solutions % -2.1% % Communication & Shipping Solutions
FIRST-QUARTER 2014 FINANCIAL INFORMATION BUSINESS NEARLY STABLE IN FIRST-QUARTER 2014 Sales rose 0.3% at rates (organic1 growth: - 0.4%) FULL-YEAR 2014 OUTLOOK UNCHANGED +1% to +3% organic growth in sales
More information2011 THIRD-QUARTER EARNINGS
2011 THIRD-QUARTER EARNINGS Paris, November 14th, 2011-8:00 am CET Board of Directors meeting on November 10th, 2011 Revenues: 54.5 million euros, down 20% compared with the third quarter of 2010, linked
More informationHIGH-TECH INDUSTRIES ENERGY TRANSITION KEY INFO IN POINTS
HIGH-TECH INDUSTRIES ENERGY TRANSITION KEY INFO IN 10 POINTS 1 #2 PRODUCER IN EUROPE In 2016, France was Europe s second largest producer of renewable energies (23.9 million tonnes of oil equivalent),
More information2018 RESULTS. 2019: a year devoted to developing innovative patient-centred solutions. Project to acquire an equity stake in Pharmathek
Villers-lès-Nancy, 29 March 2019-6:30 p.m. (CET) PRESS RELEASE 2018 RESULTS Revenue: +14.5% to 148.48m o A period combining significant organic and external growth o Tele-consultation, telecare, expansion
More informationCompany Report Daring to be different
Company Report 2010 Daring to be different Daring to be different Galapagos has continued to follow its own unique path and is now a leading international biotechnology company. In our 2010 report, we
More informationFirst Half Revenue 2005 First Half Organic growth up +2.2%
PRESS RELEASE Suresnes, August 3, 2005 First Half Revenue 2005 First Half Organic growth up +2.2% Organic growth of +3% in second quarter 2005, vs +1.4% in the first quarter Net New Business 1 of approximately
More informationEconomist Intelligence Unit Tech Sector Barometer
Economist Intelligence Unit Tech Sector Barometer Looking up October 2009 Economist Intelligence Unit 26 Red Lion Square London WC1R 4HQ United Kingdom The Economist Intelligence Unit The Economist Intelligence
More informationCOMPUTERSHARE ACQUIRES SPECIALIST STOCK PLAN MANAGEMENT BUSINESS
MARKET ANNOUNCEMENT COMPUTERSHARE ACQUIRES SPECIALIST STOCK PLAN MANAGEMENT BUSINESS 19 February 2004 - Computershare Limited (ASX: CPU) announced today its acquisition of US-based Transcentive Inc., for
More informationAxway Presentation of the results for the first half of 2014 July 25, 2014
Presentation of the results for the first half of 2014 July 25, 2014 Contents Business analysis 1 1 Chief Executive Officer 1 Financial results 4 Patrick Donovan 4 Administrative and Financial Director
More informationCertain unaudited financial and operational information for the nine months and three months ended 30 September 2018.
TCL Electronics Sales Volume of TV Sets Exceeds 21.12 Million for the First Three Quarters of 2018 Turnover of HK$32.8 Billion Reaches Record High for the Same Period * * * * * * Sustains Impressive Growth
More informationTheradiag reports its 2017 annual results and sales for first quarter 2018
Theradiag reports its 2017 annual results and sales for first quarter 2018 Consolidated 2017 revenue: 9.1 million Discontinuation of the Prestizia activity and termination of agreements with HOB Biotech,
More informationSODEXO DIGEST FISCAL 2013
SODEXO DIGEST FISCAL 2013 OUR FUNDAMENTAL DEVELOPMENT PRINCIPLES Sodexo, founded in 1966 in Marseilles, France, by Pierre Bellon, Chairman of the Board of Directors, is built on fundamental principles
More informationSUPPLEMENT TO THE GOVERNMENT S BUDGETARY POLICY ACTION. Support for the Biotechnology Sector
SUPPLEMENT TO THE GOVERNMENT S BUDGETARY POLICY 2002-2003 ACTION Support for the Biotechnology Sector Support for the Biotechnology Sector ISBN 2-550-38981-6 Legal deposit Bibliothèque nationale du Québec,
More informationPRESENTATION OF TOPSIL. AU investor event September 2 nd 2015
PRESENTATION OF TOPSIL AU investor event September 2 nd 2015 AGENDA Topsil in brief Our business Strategy and business update Questions 2 Presentation of Topsil DEDICATED TO HIGH QUALITY SILICON MANUFACTURE
More informationThe Active Biotech Group Interim Report January March 2001
The Active Biotech Group Interim Report January March 2001 Both key projects, SAIK-MS and TTS, are proceeding to Phase II clinical trials Increased focus on research projects in Lund Financing through
More informationFY2007 Full Year Results August 2007
FY2007 Full Year Results August 2007 Highlights Revenue growth, +28% EBITDA growth, +39% Profit growth, +24% NPAT Excluding non-recurring items Ellex brand sales strong +55% growth, 96% of total revenue
More informationICON plc. JP Morgan 33 rd Annual Healthcare Conference. Mr Ciaran Murray, Chief Executive Officer, ICON Plc 13 TH Jan 2015
ICON plc JP Morgan 33 rd Annual Healthcare Conference Mr Ciaran Murray, Chief Executive Officer, ICON Plc 13 TH Jan 2015 Forward Looking Statements Certain statements in today s presentation will be forward
More informationTheranexus files its registration document as part of its planned Initial Public Offering (IPO) on the Euronext Growth market in Paris
This press release cannot be published, transmitted or distributed, directly or indirectly, in the United States, South Africa, Canada, Australia or Japan. This press release does not constitute an offer
More informationTECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT
Specialist in tissue analysis by Histology, Immunohistochemistry and In Situ Hybridization TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT CONTENTS Histalim: who we are Our areas of expertise
More informationRESEARCH NOTE NETSUITE S IMPACT ON WHOLESALE AND DISTRIBUTION COMPANIES
Document L11 RESEARCH NOTE NETSUITE S IMPACT ON WHOLESALE AND DISTRIBUTION COMPANIES THE BOTTOM LINE When Nucleus examined wholesale and distribution customers using NetSuite, analysts found it enabled
More informationNeas Energy A/S. Electrolysis for grid balancing - BioCat European Power-to-Gas Platform: Second meeting Square Hotel, Copenhagen, 22 June 2016
Neas Energy A/S Electrolysis for grid balancing - BioCat European Power-to-Gas Platform: Second meeting Square Hotel, Copenhagen, 22 June 2016 Agenda Neas Energy Electricity markets Trading strategy and
More informationDevelop YOUR business in Medicon Valley Dedicated to helping you develop your business, Medicon Valley offers:
MEDICON VALLEY / 2011 03 Develop YOUR business in Medicon Valley Dedicated to helping you develop your business, Medicon Valley offers: > A pool of highly qualified life-science university graduates and
More informationBIOTECH IN FRANCE. key info in. points
BIOTECH IN FRANCE 10 key info in points 1 2 3 INSERM: EUROPE S #1 ACADEMIC BIOTECH RESEARCH INSTITUTE INSERM spearheads healthcare and medical research in France, filing more biotech patents with the European
More information2012 European Integrated Point-of-Care Diagnostic Platforms Technology Innovation Award
2012 2012 European Integrated Point-of-Care Diagnostic Platforms Technology Innovation Award 2012 Frost & Sullivan 1 We Accelerate Growth 2012 European Integrated Point-of-Care Diagnostic Platforms Technology
More informationITALIAN HI-TECH INDUSTRY: THE CASE OF LIFE SCIENCES
ITALIAN HI-TECH INDUSTRY: THE CASE OF LIFE SCIENCES Part Two Executive summary National Interest January 2015 Study conducted by the IMT Institute for Advanced Studies Lucca, the Fondazione CERM, AIFA,
More informationPromoting the Biotechnology Industry in Germany
Positions Promoting the Biotechnology Industry in Germany Germany s biotechnology industry ranks among the most sustainable and forward looking of today s cutting-edge technologies. Biotechnology is about
More informationOPERATOR STRATEGIES FOR TV AND VIDEO CONTENT: PRODUCTION, CONTENT TYPES AND DISTRIBUTION
analysysmason.com RESEARCH STRATEGY REPORT OPERATOR STRATEGIES FOR TV AND VIDEO CONTENT: PRODUCTION, CONTENT TYPES AND DISTRIBUTION MARTIN SCOTT and HEENU NIHALANI About this report Video consumption,
More informationPRESS RELEASE FIRST QUARTER 2016 FIRST QUARTER SALES Paris, June 1, 2016
FIRST QUARTER SALES 2016 FIRST QUARTER 2016 Q1 2016 sales down 2.8% at constant 1 scope and exchange rates Decline in the SME Solutions division's sales: down 4.0%, at constant exchange rates Continued
More informationCEGEDIM: STRONG COMMERCIAL REBOUND, FY 2010 OUTLOOK UNCHANGED
PRESS RELEASE QUARTERLY FINANCIAL INFORMATION AS OF MARCH 31, 2010 (IFRS REGULATED INFORMATION NOT AUDITED) CEGEDIM: STRONG COMMERCIAL REBOUND, FY 2010 OUTLOOK UNCHANGED Paris, May 6, 2010 - Cegedim, a
More informationSOCIO-ECONOMIC FOOTPRINT
SOCIO-ECONOMIC FOOTPRINT First-ever socio-economic impact study published by a private equity company April 2018 In partnership with MEASUREMENT OF EURAZEO PME S SOCIO-ECONOMIC FOOTPRINT A new milestone
More informationOPERATOR APPROACHES TO IoT: FROM CONNECTIVITY TO PLATFORMS AND FULL SOLUTIONS
analysysmason.com RESEARCH STRATEGY REPORT OPERATOR APPROACHES TO IoT: FROM CONNECTIVITY TO PLATFORMS AND FULL SOLUTIONS TOM REBBECK Analysys Mason Limited 2016 About this report This report analyses the
More informationUniversity of Connecticut Student Managed Fund 2018 Analyst Report. Jonathan Stryjek & Michael Pehota
University of Connecticut Student Managed Fund 2018 Analyst Report Jonathan Stryjek & Michael Pehota Table of Contents 3 Report Highlights 4 Business Overview 5 Industry Overview and Competitive Positioning
More information2014 Edition of the Branham300
2014 Edition of the Branham300 45 O Connor Street, Suite 1150 Ottawa, ON Canada K1P 1A4 Tel: 613.745.2282 Fax: 613.745.4990 www.branhamgroup.com Press Release 2014 Edition of the Branham300: Canada s Definitive
More information2013 EMPLOYEE INTENTIONS REPORT. Michael Page new zealand. Worldwide leaders in specialist recruitment
2013 EMPLOYEE INTENTIONS REPORT Michael Page new zealand Worldwide leaders in specialist recruitment Key Findings New Zealand s economy is currently stable and within this climate, businesses are focusing
More informationLetter to Schneider Electric Shareholders
Actionn 31 Letter to Schneider Electric Shareholders 1 solutions provider 1 leader in the new economies 1 global company Schneider Electric s new company programme Dear Shareholder, New 2, our company
More informationGeneva European Midcap Event. December 1 st, 2016
Geneva European Midcap Event December 1 st, 2016 AGENDA 01 About Wavestone Page 3 02 Financial results Page 8 03 Building Wavestone Page 14 04 Outlook Page 18 2 / 01 About Wavestone In a world where permanent
More information2012 North American Clinical Laboratory Competitive Strategy Leadership Award
2012 2012 North American Clinical Laboratory Competitive Strategy Leadership Award 2012 Frost & Sullivan 1 We Accelerate Growth Competitive Strategy Leadership Award Clinical Laboratory, North America,
More informationGerman Downstream Powerhouse
German Downstream Powerhouse Bernd Böddeling CFO RWE Deutschland Essen, 7 April 2016 Forward Looking Statement This presentation contains certain forward-looking statements within the meaning of the US
More informationTobias Spindler, Tomas Voska, David Kiss, Sahar Erfani IDENTIFICATION OF ISSUES AND RECOMMENDATION
International Marketing and Brand Management - Case Analysis Medi-Cult Tobias Spindler, Tomas Voska, David Kiss, Sahar Erfani IDENTIFICATION OF ISSUES AND RECOMMENDATION In introducing the In Vitro Maturation
More informationDear shareholders, Víctor Grífols President and CEO of Grifols
ANNUAL 2012 REPORT Dear shareholders, Grifols ushered in a new era in 2012, one that has seen the company become the world s third-largest producer of plasma-derived medicines following the acquisition
More informationI am Takeshi Okazaki, Group Executive Vice President and CFO at Fast Retailing.
I am Takeshi Okazaki, Group Executive Vice President and CFO at Fast Retailing. Today, I would like to run through our consolidated business performance for the third quarter of fiscal 2018, or the nine
More informationSummary Translation of Question & Answer Session at 2015 Nomura Investment Forum
Summary Translation of Question & Answer Session at 2015 Nomura Investment Forum Date: December 1, 2015 Location: Palace Hotel, Tokyo Presenter: Tatsuya Tanaka, President and Representative Director Q:
More information2011 Global Frost & Sullivan Product Innovation Award for RFID UHF Solutions
2011 2011 Global Frost & Sullivan Product Innovation Award for RFID UHF Solutions 2011 Frost & Sullivan 1 We Accelerate Growth Frost & Sullivan s Global Research Platform The 2011 Global Frost & Sullivan
More informationThe Low Carbon Transition in Europe: Perspectives from an Infrastructure Investor
The Low Carbon Transition in Europe: Perspectives from an Infrastructure Investor September 2017 Meridiam at a glance A leading developer, investor and asset manager specializing in greenfield infrastructure
More informationHigh Intensity Focused Ultrasound (HIFU) - Company Profile, Product Analysis and Recent Development of 20 HIFU Manufacturers
High Intensity Focused Ultrasound (HIFU) - Company Profile, Product Analysis and Recent Development of 20 HIFU Manufacturers High Intensity Focused Ultrasound (HIFU) - Company Profile, Product Analysis
More informationSTÄMPFLI PRODUCTION MEDTECH SERVICES
STÄMPFLI PRODUCTION MEDTECH SERVICES Driving your success in communication is our passion. STÄMPFLI LTD. Communication person to person The Stämpfli Group is at home in the world of printed and electronic
More informationFresenius Investor News
health care worldwide August 3, 2006 Contact: Birgit Grund Fresenius AG Investor Relations Tel. ++49-6172 - 608 2485 Fax ++49-6172 - 608 2488 e-mail: ir-fre@fresenius.de Internet: www.fresenius-ag.com
More informationNew stage in industrial development and organizational adjustments for future growth
METabolic EXplorer: third quarter 2009 activity update. First nine months of year show that the company has reached a new stage in its development and can now be qualified as a full-blown industrial undertaking
More informationIoT VALUE CHAIN REVENUE: WORLDWIDE TRENDS AND FORECASTS
RESEARCH FORECAST REPORT IoT VALUE CHAIN REVENUE: WORLDWIDE TRENDS AND FORECASTS 2016 2025 MICHELE MACKENZIE and ANDREW CHEUNG analysysmason.com About this report This report analyses revenue from the
More informationFirst quarter 2006 revenue of 339 million, compared with 330 million in Q Net new business 1 : 620 million, versus 39 million in Q1 2005
PRESS RELEASE Suresnes, May 11, 2006, 7.30 a.m. First quarter 2006 revenue of 339 million, compared with 330 million in Q1 2005 Net new business 1 : 620 million, versus 39 million in Q1 2005 Havas announces
More informationPress Release. 15 October BIOTECHNICA 2015 (6 8 October, Tue. Thu.)
Press Release 15 October 2014 BIOTECHNICA 2015 (6 8 October, Tue. Thu.) Heading for a bright biotech future: Biotech business made in Hannover BIOTECHNICA 2015: Where technology meets investors Keynote
More information(212) Cellectis Media Contact: Philippe Valachs +33(0)
For immediate release: June 18, 2014 Pfizer Media Contact: Dean Mastrojohn (212) 733-6944 dean.mastrojohn@pfizer.com Cellectis Media Contact: Philippe Valachs +33(0)1 81 69 16 00 media@cellectis.com Pfizer
More informationThe European Medical Technology Industry. in figures / 2018
The European Medical Technology Industry in figures / 2018 Table of contents What is Medical Technology? 4 Innovation 10 Employment 14 Companies 18 Expenditure on Medical Technology 20 MedTech Market in
More informationMagic Software Reports Third Quarter Financial Results
Magic Software Reports Third Quarter Financial Results Or Yehuda, Israel; November 9, 2006 -- Magic Software Enterprises Ltd. (Nasdaq: MGIC), a leading provider of state-of-the-art business integration
More informationLocalization World Silicon Valley Know-how for Global Success
Sponsorship Brochure Be a Localization World Sponsor Localization World has become the most respected event in the language industry. Show your leadership by becoming a visible representative of the entire
More informationIdorsia Company Profile
Idorsia Headquartered in Switzerland - a biotech-hub of Europe - Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has
More informationRecord organic growth: +7.1% for full year % in Q4
Suresnes, February 14, 2008, 07h35 PRESS RELEASE Record organic growth: +7.1% for full year 2007 +9.8% in Q4 «The growth reported by Havas in 2007 is above our expectations and confirms the turnaround
More information2007 Annual Results Announcement. 14 April 2008
2007 Annual Results Announcement 14 April 2008 Agenda 1. Financial Highlights 2. Business Review A. Brand Business B. OEM Business 3. Marketing & Promotion 4. Prospects A. Daphne B. Shoebox C. adidas D.
More informationaap Implantate AG Corporate Presentation German Equity Forum 2018 Bruke Seyoum Alemu, CEO Marek Hahn, CFO
aap Implantate AG Corporate Presentation German Equity Forum 2018 Making Trauma Treatment Better and Cost-Effective Bruke Seyoum Alemu, CEO Marek Hahn, CFO Frankfurt am Main, November 27, 2018 Safe Harbor
More informationAMBITION TO LEAD THE ZERO CARBON TRANSITION
Press release 28 February 2019 ENGIE Capital Markets Day AMBITION TO LEAD THE ZERO CARBON TRANSITION FOCUSED STRATEGY TARGETING CORPORATES AND LOCAL GOVERNMENTS SELECTIVE INVESTMENTS TO DRIVE ACCELERATED
More informationHCL TECHNOLOGIES REPORTS Q 1 RESULTS. NET INCOME UP 151% - crosses $ 21 million. REVENUES cross $ 69 million
HCL TECHNOLOGIES REPORTS Q 1 RESULTS NET INCOME UP 151% - crosses $ 21 million REVENUES cross $ 69 million For immediate release October 20, 2000 Executive Summary Financial Highlights (Unaudited US GAAP
More informationChina imyth FROM METAL TRADING TO MEDICAL AESTHETICS. Albedo Limited s proposed diversification through purchase of 51% of China imyth
China imyth FROM METAL TRADING TO MEDICAL AESTHETICS Albedo Limited s proposed diversification through purchase of 51% of China imyth Media Briefing 14 August 2015 Disclaimer This presentation may contain
More informationEMARSYS PARTNER PROGRAM
EMARSYS PARTNER PROGRAM CONTENTS EMARSYS PARTNER COMMUNITY 3 PARTNER PROGRAM TYPES 5 AGENCY PARTNER PROGRAM 6 REFERRAL PARTNER PROGRAM 8 RESELLER PARTNER PROGRAM 12 EMARSYS PARTNER COMMUNITY 4 EMARSYS
More informationAnnual Results April 2016
Annual Results 2015 April 2016 Summary Antevenio: a brief summary 3 complementary business units 2015: a winning repositioning strategy A sustained profitable growth Antevenio Résultats 2015 2 Part 1 Antevenio:
More informationTMT CONFERENCE Morgan Stanley November 20 th Doha, QATAR
TMT CONFERENCE Morgan Stanley November 20 th 2008 Doha, QATAR 1 OUTDOOR INDUSTRY, Structural growth opportunities JCDECAUX COMPETITIVE ADVANTAGE, A market leader FINANCIAL HIGHLIGHTS A robust financial
More informationMore information. Page 2
GenSight Biologics, Pixium Vision and Fondation Voir et Entendre join forces and benefit from a total 18.5 million funding for SIGHT AGAIN as part of the Investment for the Future This public - private
More informationGrowth transformation: Delivering on a diversified set of e-commerce growth strategies
Growth transformation: Delivering on a diversified set of e-commerce growth strategies October 2017 Successful marketers shift strategies and roles to develop the technology, capabilities, and mind-set
More informationepldt TO ACQUIRE 100% OF SPI TECHNOLOGIES, INC.; ACQUISITION TO CREATE THE LARGEST FULL SERVICE BUSINESS PROCESS OUTSOURCING FIRM IN THE PHILIPPINES
Thursday, 25 May 2006 epldt TO ACQUIRE 100% OF SPI TECHNOLOGIES, INC.; ACQUISITION TO CREATE THE LARGEST FULL SERVICE BUSINESS PROCESS OUTSOURCING FIRM IN THE PHILIPPINES The attached press release was
More informationDASSAULT SYSTEMES 2015 Second Quarter Conference Call Thursday, July 23, 2015
DASSAULT SYSTEMES 2015 Second Quarter Conference Call Thursday, July 23, 2015 François-José Bordonado Vice President, Investor Relations Thank you for joining Bernard Charlès, CEO, and Thibault de Tersant,
More informationThe role of patients in clinical research
Biopeople Newsletter April: The role of patients in clinical research Pitch your life sc...page 1 of 10 Biopeople Newsletter April 2018 The role of patients in clinical research What is the place of patients
More informationFor personal use only
31 May 2018 ASX ANNOUNCEMENT Executive Chairman s Address to be delivered at the Company s Annual General Meeting Limited (ASX: EN1 and EN1O) is pleased to provide a copy of the Executive Chairman s address
More informationCopyright NIHON KOHDEN CORPORATION All Rights Reserved
1 Overall sales increased 3.1% over the 1 st half of FY2017 to 79 billion. Domestic sales increased 2.9% to 57.8 billion. Overseas sales increased 3.8% to 21.1 billion, a 4% growth on a local currency
More informationPricing strategy and optimization to steer traffic and profitability
Pricing strategy and optimization to steer traffic and profitability Presentation of Simon-Kucher s Restaurant Practice November 2017 david.vidal@simon-kucher.com www.simon-kucher.com Simon-Kucher & Partners
More informationBest practice for communicating R&D progress to investors and the public
Best practice for communicating R&D progress to investors and the public Developed in collaboration with CONSILIUM strategic communica ons What is the purpose of this guide? Ensuring investors and the
More informationACHIEVING COMPETITIVE ADVANTAGE WITH ANATOMY AND PHYSIOLOGY
Pioneering the Exploration of the Human Body ACHIEVING COMPETITIVE ADVANTAGE WITH ANATOMY AND PHYSIOLOGY The healthcare and life sciences industries are becoming more crowded each day, as companies compete
More informationFresenius Investor News
health care worldwide October 31, 2006 Contact: Birgit Grund Fresenius AG Investor Relations Tel. ++49-6172 - 608 2485 Fax ++49-6172 - 608 2488 e-mail: ir-fre@fresenius.de Internet: www.fresenius-ag.com
More informationSpecial Issue. Mesoblast Limited
Overview is an Australian biotechnology company committed to the commercialization of novel treatments for orthopedic conditions by using its unique adult stem cell technology for the regeneration and
More informationICON plc Brendan Brennan CFO
ICON plc Brendan Brennan CFO Jefferies HealthCare Conference New York 6 TH June 2017 Forward Looking Statement Certain statements will be forward looking statements. Actual results may differ materially
More informationHelping unlock growth opportunities worldwide
Helping unlock growth opportunities worldwide A trusted partner for high-stakes decisions While scientific and technological advances fuel new business opportunities, the cost of bringing each new product
More informationCHARLTONS. New Rules Listing Biotech Companies on the Hong Kong Stock Exchange
CHARLTONS New Rules Listing Biotech Companies on the Hong Kong Stock Exchange 0 INTRODUCTION The Hong Kong Stock Exchange (the Exchange) published its Consultation Conclusions on a Listing Regime for Companies
More information2017 HIGH GROWTH STUDY. Research Summary
2017 HIGH GROWTH STUDY Research Summary 2017 High Growth Study: Research Summary Copyright 2017 Published by Hinge Research Institute 1851 Alexander Bell Drive, Suite 350, Reston, Virginia 20191 All rights
More informationInterim Results Presentation 17 August
Interim Results Presentation 17 August BUSINESS REVIEW AND OUTLOOK BRAND + PRODUCT Cherry Chen ( 陳晨 ), Executive Director and Brand VP FULL ENHANCEMENT OF BRAND VALUE Reinforcement and emphasis of brand
More informationOn behalf of the Cystic Fibrosis Foundation (CFF) and the 30,000 people with cystic
Robert J. Beall, Ph.D. President and Chief Executive Officer Cystic Fibrosis Foundation On behalf of the Cystic Fibrosis Foundation (CFF) and the 30,000 people with cystic fibrosis (CF) in the United States,
More informationOUR SOLUTIONS. YOUR SUCCESS.
OUR SOLUTIONS. YOUR SUCCESS. Practice management software and hardware Training and technical support Online data backup Credit card processing Client communications tools Diagnostics 855.838.7638 sales@avimark.net
More informationMODULAR SERVICE AGREEMENTS THE KEY TO CONTINUOUS PERFORMANCE. SICK LifeTime Services
MODULAR SERVICE AGREEMENTS THE KEY TO CONTINUOUS PERFORMANCE SICK LifeTime Services SICK LifeTime Services THE RIGHT SERVICE FOR ANYTIME AND EVERYWHERE With SICK at your side, you will have a service partner
More informationOliver Wyman study Wind Power 2020: Boom-Market Service The underestimated profit machine
You can receive print-ready photos by e-mail. Please submit your request to andrea.steverding@oliverwyman.com. P R E S S R E L E A S E Oliver Wyman study Wind Power 2020: Boom-Market Service The underestimated
More informationBiotechnology Certificate New Technologies For Health
Weekly Barometer 25 janvier 2012 Biotechnology Certificate New Technologies For Health January 2018 ATONRÂ PARTNERS SA 12, Rue Pierre Fatio 1204 GENEVA SWITZERLAND - Tel: + 41 22 310 15 01 http://www.atonra.ch
More informationSODEXO DIGEST
SODEXO DIGEST 2015-2016 CONSOLIDATED REVENUES BY GEOGRAPHIC AREA IN 2016 43% North America 11% United Kingdom and Ireland 30% Continental Europe 16% Rest of the world 2 Founded in 1966 by Pierre Bellon
More informationSubmissions from entities in the United Nations system and elsewhere on their efforts in 2015 to implement the outcome of the WSIS
COMMISSION ON SCIENCE AND TECHNOLOGY FOR DEVELOPMENT (CSTD) Eighteenth Session Geneva, 9 to 13 May 2016 Submissions from entities in the United Nations system and elsewhere on their efforts in 2015 to
More informationCircular Advantage Innovative Business Models and Technologies to Create
Circular Advantage Innovative Business Models and Technologies to Create Value in a World without Limits to Growth Nobuko Asakai Introduction to Accenture Committed to delivering innovation, Accenture
More informationCOMPANY PROFILE
COMPANY PROFILE 2017 www.dronevolt.com Company Profile 2017 DRONE VOLT ALL RIGHT RESERVED Introduction Professional drones and drones for professional solutions. 2 SECURITY CONSTRUCTION AGRICULTURE AUDIOVISUAL
More informationEvent Sponsorship Opportunities
Medicon Valley Alliance Arne Jacobsens Allé 15, 2. 2300 Copenhagen S Denmark Medicon Valley Alliance Event Sponsorship Opportunities www.mva.org +45 7020 1503 Creating Value for Your Company Sponsoring
More informationUniversal Biosensors, Inc.
Universal Biosensors, Inc. ARBN 121 559 993 UBS Australian Healthcare Conference November 2011 1 Important Disclaimer This presentation is intended to provide a general outline only and is not intended
More informationArtificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle
Volume XX, Issue 60 Artificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle Artificial intelligence (AI) has the potential to transform the pharmaceutical industry.
More information